Jubilant Life Sciences’ wholly-owned subsidiary -- Jubilant DraxImage Inc (JDI) and Cyclopharm (CYC) have mutually terminated their previously announced term sheet for exclusive commercial rights of Technegas in the US market. Both parties have agreed to discuss potential commercial opportunities once CYC obtains USFDA approval for Technegas.
Jubilant Life Sciences is engaged in manufacturing and supplying of application program interface (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products and life science ingredients like advance intermediates (pyridine and picoline), fine ingredients (pyridine and picoline derivatives for pharmaceuticals and others, crop science ingredients (pyridine and picoline derivatives for agrochemicals), nutritional products (vitamin B3- niacinamide and niacin, choline chloride and premixes) and life science chemicals (acetyls).
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: